Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial

We characterized the fatty acid profiles in the erythrocyte membrane of pediatric patients with cystic fibrosis (CF) receiving highly concentrated docosahexaenoic acid (DHA) supplementation (Tridocosahexanoin-AOX(®) 70%) at 50 mg/kg/day (n = 11) or matching placebo (n = 11) for 12 months. The mean a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayats-Vidal, Roser, Bosque-García, Montserrat, Cordobilla, Begoña, Asensio-De la Cruz, Oscar, García-González, Miguel, Castro-Marrero, Jesús, López-Rico, Irene, Domingo, Joan Carles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253750/
https://www.ncbi.nlm.nih.gov/pubmed/37297899
http://dx.doi.org/10.3390/jcm12113704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253750/
https://www.ncbi.nlm.nih.gov/pubmed/37297899
http://dx.doi.org/10.3390/jcm12113704

Ejemplares similares